Pharmaceuticals
-
AUY, MULN, TXMD, TMBR, HUSA: Trending Stocks Today 31 May
Tuesday's trending stocks include the likes of Yamana Gold (NYSE: AUY), Mullen Automotive (NASDAQ: MULN) and TherapeuticsMD (NASDAQ: TXMD).
-
Comera Life Sciences IPO: What You Need to Know
Comera Life Sciences Holdings (NASDAQ: CMRA) $159m IPO.
-
Cardiol's Heart Failure Treatment Offers Hope to Diabetics
We're discussing diabetes and heart failure with reference to Eli Lilly & Co. (NYSE: LLY), Novo Nordisk (NYSE: NVO), Sanofi (NASDAQ: SNY) and...
-
Bausch + Lomb IPO: A Good Investment?
Bausch + Lomb is about to go public with an IPO, so we're taking a look at the stock to see if there's a clear case for investing.
-
Algernon Pharma IPO: What You Need to Know
Algernon Pharma (CSE: AGN, FRANKFURT: AGWO, OTCQB: AGNPF) plans to list on the NASDAQ Capital Market in an IPO.
-
Is Rocket Pharmaceuticals Stock (RCKT) One to Watch in 2022?
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) hopes to use gene therapy to cure pediatric diseases. RCKT stock has been rising this month. Is it a buy?
-
SRRA Shares Higher: Sierra Oncology Cancer Drug Shines in Testing
Sierra Oncology (NASDAQ: SRRA) shares leapt by more than 25% on Wednesday after a breakthrough in the firm's quest to commercialize a blood cancer...
-
MRNA, PFE, BNTX, FSR, NVAX: Which Stocks are Trending Today 29 Nov?
A small recovery is expected on Monday morning after markets took a beating on Black Friday, with pharma continuing to rise and some travel stocks...
-
Is Pfizer Stock a Buy as COVID Pills Gear Up for Approval?
Pfizer's COVID-19 pill, vaccine and CFO resignation are making headlines this week. Does the news help boost its investment thesis?
-
The HighBrid Lab blends complementary therapies amid rising investor interest
Creso Pharma is joining forces with long-established psychedelics business Red Light Holland Corp.
-
Why Creso Pharma is Set to Be First-Mover in New Corner of Projected $16 Trillion Market
Creso Pharma's revolutionary approach to treating the $16 trillion mental health problem.
-
This firm is taking a diversified approach to two novel sectors helping millions worldwide...
Creso Pharma are entering a brand-new booming market as it rides the second green wave.
-
Biotech stock Cardiol Therapeutics makes progress with clinical trial
Cardiol Therapeutics advances CardiolRx trial with its first Covid-19 positive patient. The CBD formulation may hold the key to reducing CVD...
-
Agreement to acquire established Canadian psychedelics company Halucenex Life Sciences Inc.
Creso Pharma has signed an agreement to acquire Halucenex Life Sciences, an established psychedelics company focused on developing treatments...
-
This Company Has Developed a Range of Market-Leading Complementary Feed Products Specifically Formulated For Pets...
-
Pharma’s $7.2 Billion CBD Acquisition Could Trigger New Biotech Boom